Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts

Journal of Bone and Mineral Research

Volumn 12, Issue 7, 1997, Pages 1009-1017

  Guo, Rong ^a   Quarles, L Darryl ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; PHOSPHATE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HYPOPHOSPHATEMIA; MOLECULAR CLONING; MOUSE; NONHUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYPOPHOSPHATEMIA; LINKAGE (GENETICS); MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEPRILYSIN; OSTEOBLASTS; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; POLYMERASE CHAIN REACTION; PROTEINS; X CHROMOSOME;

EID: 0030954146     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.7.1009     Document Type: Article

References (38)

1. Econs MJ 1996 Positional cloning of the Hyp gene: A review. Kidney Int 49:1033-1037.
2. The HYP Consortium 1995 A gene (Pex) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet 11:130-136.
3. Tenenhouse HS, Scriver CR 1992 X-linked hypophosphatemia: A phenotype in search of a cause. Int J Biochem 24:685-691.
4. Hruska KA, Rifas L, Cheng SL, Gupta A, Halstead L, Avioli L 1995 X-linked hypophosphatemic rickets and the murine Hyp homologue. Am J Physiol 268:F357-F362.
5. Econs MJ, Drezner MK 1994 Tumor-induced osteomalacia -Unveiling a new hormone. N Engl J Med 330:1679-1681.
6. Nesbitt T, Coffman TM, Griffiths R, Drezner MK 1992 Crosstransplantation of kidneys in normal and Hyp mice: Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest 89:1453-1459.
7. Meyer RA, Tenenhouse HS Jr, Meyer MH, Klugerman AH 1989 The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. J Bone Miner Res 4:523-532.
8. Nesbitt T, Econs MJ, Byun JK, Martel J, Tenenhouse HS Jr, Drezner MK 1995 Phosphate transport in immortalized cell cultures from the renal proximal tubule of normal and Hyp mice: Evidence that the Hyp gene locus product is an extrarenal factor. J Bone Miner Res 10:1327-1333.
9. Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, Ecarot B 1996 cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36:22-28.
10. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L 1992 Defective bone formation by Hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 7:215-220.
11. Gundberg CM, Clough ME, Carpenter TO 1992 Development and validation of a radioimmunoassay for mouse osteocalcin: Paradoxical response in the Hyp mouse. Endocrinology 130: 1909-1915.
12. 3-treated rat osteoblast-like cells. Pflugers Arch 430:64-67.
13. Lajeunesse D, Aubin R 1996 Demonstration of a primary defect in osteogenic stromal stem cells from the Hyp mouse: A cause for hypophosphatemia? J Bone Miner Res 11:S136.
14. Fisher LW, McBride OW, Termine JD, Young MF 1990 Human bone sialoprotein: Deduced protein sequence and chromosomal localization. J Biol Chem 265:2347-2351.
15. Clover J, Gowen M 1994 Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15:585-591.
16. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ 1992 Distinct proliferative and differential stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Miner Res 7:683-692.
17. Chomezynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
18. Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA, Wozney JM 1986 Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 5:1885-1890.
19. Sanger F, Niklen S, Coulson AR 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
20. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Salem, MA, U.S.A.
21. Sokal RR, Rohol FJ 1981 Biometry: The Principles and Practice of Statistics in Biological Research, 2nd Ed. WH Freeman, San Francisco, CA, U.S.A., p. 454.
22. Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J, Reinherz EL 1988 Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci USA 85:4819-4823.
23. Jongeneel CV, Bouvier J, Bairoch A 1989 A unique signature identified a family of zinc-dependent metallopeptidases. Fed Eur Biochem Soc 242:211-214.
24. Le Moual H, Roques BPO, Crine P, Boileau G 1993 Substitution of potential metal-coordinating amino acid residues in the zinc-binding site of endopeptidase-24.11. FEBS Lett 324:196-200.
25. Devault A, Sales V, Nault C, Beaumont A, Roques B, Crine P, Boileau G 1988 Exploration of the catalytic site of endopeptidase 24.11 by site-directed mutagenesis: Histidine residues 583 and 587 are essential for catalysis. FEBS Lett 231:54-58.
26. Le Moual H, Devault A, Roques B, Crine P, Boileau G 1991 Identification of glutamic acid 646 as a zinc-coordinating residue in endopeptidase-24.11. J Biol Chem 266:15670-15674.
27. Beaumont A, Le Moual H, Boileau G, Crine P, Roques B 1991 Evidence that both arginine 102 and arginine 747 are involved in substrate binding to neutral endopeptidase (EC 3.4.24.11). J Biol Chem 266:214-220.
28. Roques B, Noble F, Dauge V, Fournie-Zaluski M, Beaumont A 1993 Neutral endopepetidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146.
29. Tam L-T, Bengelbrecht S, Talent JM, Gracy RW, Erdos EG 1985 The importance of disulfide bridges in human endopeptidase (enkephalinase) after proteolytic cleavage. Biochem Biophys Res Commun 133:1187-1192.
30. Whyte MP 1994 Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439-461.
31. Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Foulkes JL 1995 Characterization of IGF-binding protein-5-degrading proteases produced throughout murine MC3T3-E1 osteoblast differentiation. Endocrinology 136:3527-3533.
32. Partridge NC, Winchester SK 1996 Osteoblast proteinases. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles in Bone Biology. Academic Press, New York, NY, U.S.A., pp. 207-216.
33. Benayahu D, Fried A, Shamay A, Cunningham N, Blumberg S, Weintroub S 1994 Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts. J Cell Biochem 56:62-73.
34. Aguayo SM, Schuyler WE, Murtagh JJ, Roman. J 1994 Regulation of lung branching morphogenesis by bombesin-like peptides and neutral endopeptidase. Am J Resp Cell Mol Biol 10:635-642.
35. Wenstrup RJ, Fowlkes JL, Witte DP, Florer JB 1996 Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrix. J Biol Chem 271:10271-10276.
36. Lajeunesse D, Meyer RA, Hamel L 1996 Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse. Kidney Int 50:1531-1538.
37. 3. Bone 13:209-215.
38. Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna. K 1992 A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 75:879-885.